Physician profile
Amanda Chow
NPI 1689311151
$1,220.61
in general payments reported to CMS, 2019-2025
8 companies · $322 in 2025
The $322 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $430 · 2024: $469 · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,220.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $404.85 | 2023-2025 | Avance Nerve Graft, Axoguard Ha+ Nerve Protector, Axoguard Nerve Connector |
| Mentor Worldwide LLC | $358.91 | 2023-2024 | Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Avita Medical Americas, LLC | $151.88 | 2023 | Recell |
| Ethicon US, LLC | $116.42 | 2024 | Stratafix, Surgicel Nu-Knit, Dermabond |
| Polynovo North America LLC | $78.35 | 2025 | Novosorb Btm |
| Kerecis Limited | $59.82 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Acera Surgical, INC. | $27.09 | 2025 | Restrata Wound Matrix |
| Abbvie INC. | $23.29 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Chow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.